mFlusiva becomes the first mRNA influenza vaccine approved by the FDA
1. The FLUENT trial demonstrated 26.6% relative vaccine efficacy over a standard-dose comparator in adults 50 and older, clearing the ...
Tag: mFlusiva
FDA Advisory Committee Votes Unanimously to Recommend Moderna’s mRNA Flu Vaccine
1. The FDA's top vaccine advisory committee voted 9-0 on June 18, 2026 to recommend Moderna's mRNA influenza vaccine mFlusiva ...
